A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
Conditions
Castration-Resistant Prostatic Cancer · Metastasis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
UCLA Hematology & Oncology ( Site 0003), Los Angeles, California, United States
UCSF Medical Center at Mission Bay ( Site 0034), San Francisco, California, United States
MedStar Georgetown Cancer Institute at MedStar Washington Hospital Center ( Site 0026), Washington D.C., District of Columbia, United States
Memorial Sloan Kettering Cancer Center ( Site 0006), New York, New York, United States
UPMC Hillman Cancer Center ( Site 0014), Pittsburgh, Pennsylvania, United States
The West Clinic, PLLC dba West Cancer Center ( Site 0005), Germantown, Tennessee, United States
Fred Hutchinson Cancer Center ( Site 0013), Seattle, Washington, United States
Instituto Alexander Fleming ( Site 0202), Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
Fundación CORI para la Investigación y Prevención del Cáncer ( Site 0200), La Rioja, Argentina
Macquarie University-MQ Health Clinical Trials Unit ( Site 0801), Macquarie University, New South Wales, Australia
Liga Norte Riograndense Contra o Câncer ( Site 0271), Natal, Rio Grande do Norte, Brazil
Irmandade da Santa Casa de Misericórdia de Porto Alegre ( Site 0270), Porto Alegre, Rio Grande do Sul, Brazil
Hospital Moinhos de Vento ( Site 0278), Porto Alegre, Rio Grande do Sul, Brazil
Hospital Universitário São Francisco de Assis - Bragança Paulista ( Site 0268), Bragança Paulista, São Paulo, Brazil
Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (USP) ( Site 0273), Ribeirão Preto, São Paulo, Brazil
Fundação Faculdade Regional de Medicina de São José do Rio Preto ( Site 0263), São José do Rio Preto, São Paulo, Brazil
Hospital Alemao Oswaldo Cruz ( Site 0279), São Paulo, São Paulo, Brazil
IPITEC ( Site 0275), São Paulo, Brazil
IBCC - Instituto Brasileiro de Controle do Câncer ( Site 0269), São Paulo, Brazil
BC Cancer - Vancouver Center ( Site 0103), Vancouver, British Columbia, Canada
Sunnybrook Research Institute ( Site 0109), Toronto, Ontario, Canada
Princess Margaret Cancer Centre ( Site 0102), Toronto, Ontario, Canada
Jewish General Hospital ( Site 0108), Montreal, Quebec, Canada
CIUSSS de l Estrie - CHUS - Centre Hosp. Univ. Sherbrooke ( Site 0107), Sherbrooke, Quebec, Canada
Clinica Universidad Catolica del Maule ( Site 0236), Talca, Maule Region, Chile
FALP ( Site 0232), Santiago, Region M. de Santiago, Chile
Centro de Oncología de Precisión ( Site 0241), Santiago, Region M. de Santiago, Chile
Bradfordhill ( Site 0231), Santiago, Region M. de Santiago, Chile
ONCOCENTRO APYS ( Site 0234), Viña del Mar, Valparaiso, Chile
Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest ( Site 0498), Bordeaux, Gironde, France
Centre Oscar Lambret ( Site 0495), Lille, Nord, France
Institut De Cancerologie De L Ouest ( Site 0494), Saint-Herblain, Pays de la Loire Region, France
Centre Hospitalier de la Côte Basque ( Site 0496), Bayonne, Pyrenees-Atlantiques, France
centre hospitalier lyon sud ( Site 0497), Pierre-Bénite, Rhone, France
NCT ( Site 0528), Heidelberg, Baden-Wurttemberg, Germany
Universitaetsklinikum Jena ( Site 0525), Jena, Thuringia, Germany
Universitaetsklinikum Hamburg-Eppendorf ( Site 0524), Hamburg, Germany
St Vincent's University Hospital ( Site 0463), Dublin, Dublin, Ireland
Beaumont Hospital, Dublin ( Site 0465), Dublin, Ireland
Tallaght University Hospital ( Site 0462), Dublin, Ireland
Rambam Health Care Campus ( Site 0400), Haifa, Israel
Rabin Medical Center ( Site 0402), Petah Tikva, Israel
Sheba Medical Center ( Site 0401), Ramat Gan, Israel
Sourasky Medical Center ( Site 0403), Tel Aviv, Israel
AOU San Luigi Gonzaga di Orbassano ( Site 0434), Orbassano, Torino, Italy
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia ( Site 0432), Brescia, Italy
Fondazione IRCCS Istituto Nazionale Dei Tumori ( Site 0431), Milan, Italy
A.O.U. Federico II di Napoli ( Site 0435), Naples, Italy
Fondazione Policlinico Universitario Agostino Gemelli ( Site 0433), Roma, Italy
Ziekenhuis Gelderse Vallei ( Site 0683), Ede, Gelderland, Netherlands
UMC St. Radboud ( Site 0679), Nijmegen, Gelderland, Netherlands
Nij Smellinghe ( Site 0684), Drachten, Provincie Friesland, Netherlands
Auckland City Hospital ( Site 0831), Auckland, New Zealand
Uniwersytecki Szpital Kliniczny w Poznaniu ( Site 0590), Poznan, Greater Poland Voivodeship, Poland
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie ( Site 0586), Warsaw, Masovian Voivodeship, Poland
Uniwersyteckie Centrum Kliniczne ( Site 0588), Gdansk, Pomeranian Voivodeship, Poland
Szpital Wojewódzki im. M.Kopernika Oddział Onk. Klinicznej z Pododdziałem Chemioterapii Jednodniowej ( Site 0587), Koszalin, West Pomeranian Voivodeship, Poland
Asan Medical Center ( Site 0925), Songpagu, Seoul, South Korea
Severance Hospital Yonsei University Health System ( Site 0924), Seoul, South Korea
Samsung Medical Center ( Site 0926), Seoul, South Korea
ICO L Hospitalet ( Site 0617), L Hospitalet Del Llobregat, Barcelona, Spain
Hospital Universitario Ramon y Cajal ( Site 0620), Madrid, Spain
Hospital Clinico San Carlos ( Site 0618), Madrid, Spain
Hospital Universitario 12 de Octubre ( Site 0622), Madrid, Spain
Hospital Universitario Virgen del Rocio ( Site 0619), Seville, Spain
Taichung Veterans General Hospital ( Site 0902), Taichung, Taiwan
Taipei Veterans General Hospital ( Site 0901), Taipei, Taiwan
Baskent University Dr. Turgut Noyan Research and Training Center ( Site 0650), Adana, Turkey (Türkiye)
Hacettepe Universitesi Tip Fakultesi ( Site 0648), Ankara, Turkey (Türkiye)
Ankara Universitesi Tip Fakultesi Hastanesi ( Site 0653), Ankara, Turkey (Türkiye)
Ankara Bilkent Şehir Hastanesi ( Site 0654), Ankara, Turkey (Türkiye)
Koç Üniversitesi Hastanesi ( Site 0656), Istanbul, Turkey (Türkiye)
Istanbul Universitesi Cerrahpasa ( Site 0649), Istanbul, Turkey (Türkiye)
Recep Tayyip Erdogan University Training and Research Hospital ( Site 0655), Rize, Turkey (Türkiye)
Addenbrooke's Hospital ( Site 0747), Cambridge, Cambridgeshire, United Kingdom
St Bartholomew's Hospital ( Site 0749), London, London, City of, United Kingdom
Royal Free Hospital ( Site 0743), London, London, City of, United Kingdom
Royal Marsden Hospital (Sutton) ( Site 0741), London, Surrey, United Kingdom
Study leads
Medical Director
Study Director
Merck Sharp & Dohme LLC